First National Bank of South Miami’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
First National Bank of South Miami's BMY Position: Q2 2023 in Review
First National Bank of South Miami reduced its Bristol-Myers Squibb (BMY) stake by 7.9% in Q2 2023, selling an estimated $64.4K and leaving 11,148 shares worth $713K. The position accounts for 0.57% of the portfolio, ranked #49.
First National Bank of South Miami first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. The position peaked at $987K in Q2 2022. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- First National Bank of South Miami held 11,148 shares of Bristol-Myers Squibb worth $713K as of Q2 2023.
- First National Bank of South Miami sold 961 Bristol-Myers Squibb shares in Q2 2023, an estimated $64.4K.
- Bristol-Myers Squibb made up 0.57% of First National Bank of South Miami's portfolio in Q2 2023, its #49 holding.
- First National Bank of South Miami first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
- First National Bank of South Miami's Bristol-Myers Squibb position peaked at $987K in Q2 2022.
- 2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.